Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2024-05-02 00:00:00 ET · period of report 2024-05-01 · accession 0001415889-24-012091 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-02 | 2024-05-01 | KYNB | Wettig Thane | CEO, Dir | F - Tax | $1.17 | -20.8K | 448.6K | -4% | -$24.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-01 | F | D | 20,840 | $1.17 | 448,556 | D | — | — | (F1) Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. |